Eton Pharmaceuticals Appoints Judith M. Matthews as New CFO
Eton Pharmaceuticals (ETON) has appointed Judith M. Matthews as its new CFO, effective June 1, succeeding James Gruber who will remain in his role until May 31 and will also provide consulting services for six months. Matthews brings over 25 years of experience in financial leadership within the pharmaceutical and biotechnology sectors.
Tickers: $ETON
Topics: CFO appointment executive changes leadership transition pharmaceutical industry